1)- Lindsey A Bennie, Helen O McCarthy, Jonathan A Coulter. Enhanced nanoparticle delivery exploiting tumour-responsive formulations.Cancer nanotechnology. 2018, 9 (1): 10
2)- Lesya Kobylinska, Igor Patereha, Natalia Finiuk, Natalia Mitina, Anna Riabtseva, Igor Kotsyumbas, Rostyslav Stoika, Alexander Zaichenko, Sandor G Vari. Comb-like PEG-containing polymeric composition as low toxic drug nanocarrier.Cancer nanotechnology. 2018, 9 (1): 11
3)- Lawrence Ochoo, Charles Migwi, John Okumu. Important parameters for optimized metal nanoparticles-aided electromagnetic field (EMF) effect on cancer.Cancer nanotechnology. 2018, 9 (1): 2
5)- Cian M McCrudden, John W McBride, Joanne McCaffrey, Emma M McErlean, Nicholas J Dunne, Vicky L Kett, Jonathan A Coulter, Tracy Robson, Helen O McCarthy. Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer.Cancer nanotechnology. 2018, 9 (1): 5
7)- Marzieh Salimi, Saeed Sarkar, Reza Saber, Hamid Delavari, Ali Mohammad Alizadeh, Hendrik Thijmen Mulder. Magnetic hyperthermia of breast cancer cells and MRI relaxometry with dendrimer-coated iron-oxide nanoparticles.Cancer nanotechnology. 2018, 9 (1): 7
8)- Larysa M Skivka, Svitlana V Prylutska, Mariia P Rudyk, Nataliia M Khranovska, Ievgeniia V Opeida, Vasyl V Hurmach, Yuriy I Prylutskyy, Leonid F Sukhodub, Uwe Ritter. C fullerene and its nanocomplexes with anticancer drugs modulate circulating phagocyte functions and dramatically increase ROS generation in transformed monocytes.Cancer nanotechnology. 2018, 9 (1): 8
9)- Jeremy M C Brown, Gerard G Hanna, Nathanael Lampe, Balder Villagomez-Bernabe, James R Nicol, Jonathan A Coulter, Fred J Currell. Towards photon radiotherapy treatment planning with high Z nanoparticle radiosensitisation agents: the Relative Biological Effective Dose (RBED) framework.Cancer nanotechnology. 2018, 9 (1): 9